Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Julphar
Daiichi Sankyo
Moodys
UBS

Generated: May 24, 2019

DrugPatentWatch Database Preview

HEPSERA Drug Profile

« Back to Dashboard

When do Hepsera patents expire, and what generic alternatives are available?

Hepsera is a drug marketed by Gilead and is included in one NDA.

The generic ingredient in HEPSERA is adefovir dipivoxil. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the adefovir dipivoxil profile page.

Drug patent expirations by year for HEPSERA
Synonyms for HEPSERA
((((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy))bis(methylene) bis(2,2-dimethylpropanoate)
(((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate
(((2-(6-AMINO-9H-PURIN-9-YL)ETHOXY)METHYL)PHOSPHORYL)BIS(OXY)BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE)
((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate
[({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate
[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
142340-99-6
2,2-dimethylpropanoic acid [2-(6-aminopurin-9-yl)ethoxymethyl-[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]oxymethyl ester
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3-phosphanon-1-yl pivalate (non-preferred
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3?5-phosphanon-1-yl 2,2-dimethylpropanoate
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3lambda~5~-phosphanon-1-yl 2,2-dimethylpropanoate
340A996
9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine
9-[2-[Bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine
9-[2-[BIS[(PIVALOYLOXY)METHOXY]PHOSPHINYL]METHOXY]ETHYL]ADENINE
A807894
AB0012816
AB01274706_02
AB01274706-01
AB07592
AB2000245
AC-1693
AC1L1U36
adefovir depivoxil
Adefovir di(pivaloyloxymethyl) ester
ADEFOVIR DIPIVOXIL
Adefovir Dipivoxil (Preveon, Hepsera)
Adefovir dipivoxil (USAN)
Adefovir dipivoxil [USAN]
Adefovir dipivoxil, Antibiotic for Culture Media Use Only
Adefovir dipivoxyl
Adefovir pivoxil
Adefovir pivoxil (JAN)
Adefovirdipivoxl
AK546547
AKOS005145737
AN-6719
ANW-43238
API0001387
ARONIS27063
B2222
BC206225
BCP0726000157
BCP22959
BCP9000232
BCPP000434
bis-POM PMEA
Bis-POM PMEA, Adefovir Dipivoxil
Bis-POM PMEA;Preveon;Hepsera;Preveon;Hepsera
Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine
BIS(PIVALOYLOXYMETHYL)-9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE
Bis(POM)-PMEA
Bis(pom)PMEA
BRD-K96159438-001-03-0
C-22950
C20H32N5O8P
CA0117
CAS-142340-99-6
CC-23770
CHEMBL922
CS-2240
CTK8B3813
D01655
DB00718
DSSTox_CID_26487
DSSTox_GSID_46487
DSSTox_RID_81658
DTXSID5046487
FT-0082875
FT-0631164
GP5823
GS 0840
GS 840
GS-0840
GS-3604
GS-840
Hepsera (TM)
Hepsera (TN)
HMS3604F09
HMS3655I04
HY-B0255
I06-1150
I14-3234
KS-00000L27
KS-000048K6
LS-173141
MCULE-6257358029
MFCD00869897
MLS003915635
MLS004774124
NCGC00164624-01
NCGC00164624-02
NCGC00164624-03
Piv2PMEA
Preveon
Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester
Propanoic acid,2,2-dimethyl-(((2-(6-amino-9H-purin-9-yl)ehtoxy)mehtyl)phosphinyldiene)bis(oxymehtylene)ester
PubChem14224
Q-101927
RP17773
RTC-070886
s1718
SCHEMBL29729
SMR002530072
SR-01000931258
SR-01000931258-2
STL257088
SW219933-1
TC-070886
TL8000938
Tox21_112243
Tox21_112243_1
U6Q8Z01514
UNII-U6Q8Z01514
W-2203
YouHeDing
ZINC3930376

US Patents and Regulatory Information for HEPSERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for HEPSERA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for HEPSERA
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 10 mg ➤ Subscribe ➤ Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Healthtrust
US Department of Justice
Covington
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.